{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T18:29:21Z","timestamp":1770748161700,"version":"3.49.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Chinese Center for Diseases Control and Prevention"},{"DOI":"10.13039\/501100004371","name":"University of Tampere","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004371","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.vaccine.2019.01.009","type":"journal-article","created":{"date-parts":[[2019,1,29]],"date-time":"2019-01-29T12:20:59Z","timestamp":1548764459000},"page":"1182-1187","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Deaths reported to national surveillance for adverse events following immunization in China, 2010\u20132015"],"prefix":"10.1016","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0327-6497","authenticated-orcid":false,"given":"Wendi","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dawei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Pekka","family":"Nuorti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keli","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Disha","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiakai","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingshan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huaqing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"S1","key":"10.1016\/j.vaccine.2019.01.009_b0005","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.vaccine.2010.02.039","article-title":"The role of the China Experts Advisory Committee on Immunization Program","volume":"28","author":"Zheng","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.01.009_b0010","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.vaccine.2012.11.051","article-title":"Systematic review of reporting rates of adverse events following immunization: An international comparison of post-marketing surveillance programs with reference to China","volume":"31","author":"Guo","year":"2013","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2019.01.009_b0015","doi-asserted-by":"crossref","first-page":"602","DOI":"10.4161\/hv.6.7.11933","article-title":"China\u2019s emerging vaccine industry","volume":"6","author":"Hendriks","year":"2010","journal-title":"Human Vacc"},{"issue":"10","key":"10.1016\/j.vaccine.2019.01.009_b0020","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.4161\/21645515.2014.971643","article-title":"Hepatitis B vaccine adverse events in China: Risk control and regulation","volume":"10","author":"Li","year":"2014","journal-title":"Human Vacc Immunotherap"},{"key":"10.1016\/j.vaccine.2019.01.009_b0025","doi-asserted-by":"crossref","first-page":"4041","DOI":"10.1016\/j.vaccine.2015.04.060","article-title":"Surveillance of adverse events following immunization in China: past, present, and future","volume":"33","author":"Liu","year":"2015","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2019.01.009_b0030","first-page":"246","article-title":"Analysis on pilot surveillance counties of adverse events following immunization in China","volume":"18","author":"Yue","year":"2012","journal-title":"Chin J Vacc Immun"},{"issue":"6","key":"10.1016\/j.vaccine.2019.01.009_b0035","first-page":"505","article-title":"Study on the surveillance of adverse events following immunization in China, 2005\u20132006","volume":"13","author":"Liu","year":"2007","journal-title":"Chin J Vacc Immun"},{"issue":"7","key":"10.1016\/j.vaccine.2019.01.009_b0040","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1056\/NEJMoa1008553","article-title":"Safety of influenza A (H1N1) vaccine in post-marketing surveillance in China","volume":"364","author":"Liang","year":"2011","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.vaccine.2019.01.009_b0045","first-page":"402","article-title":"Analysis on the adverse event following immunization after supplementary immunization activity of measles contained vaccine in China, 2010","volume":"18","author":"Wu","year":"2012","journal-title":"Chin J Vaccines Immun"},{"key":"10.1016\/j.vaccine.2019.01.009_b0050","series-title":"Food and drug administration of China","author":"China Ministry of Health","year":"2010"},{"key":"10.1016\/j.vaccine.2019.01.009_b0055","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1016\/S0264-410X(99)00132-2","article-title":"An overview of the vaccine adverse event reporting system (VAERS) as a surveillance system","volume":"17","author":"Singleton","year":"1999","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2019.01.009_b0060","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2165\/00002018-200326030-00003","article-title":"Quantitative methods in pharmacovigilance: focus on signal detection","volume":"26","author":"Hauben","year":"2003","journal-title":"Drug Saf"},{"issue":"1","key":"10.1016\/j.vaccine.2019.01.009_b0065","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.amepre.2013.02.020","article-title":"Mortality rates and cause-of-death patterns in a Vaccinated population","volume":"45","author":"Mccarthy","year":"2013","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.vaccine.2019.01.009_b0070","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1093\/cid\/civ423","article-title":"Deaths reported to the vaccine adverse event reporting system, United States, 1997\u20132013","volume":"61","author":"Moro","year":"2015","journal-title":"CID"},{"key":"10.1016\/j.vaccine.2019.01.009_b0075","series-title":"Death surveillance data report \u2013 national diseases surveillance system, 2011","author":"Chinese Center for Disease Control and Prevention","year":"2013"},{"key":"10.1016\/j.vaccine.2019.01.009_b0080","first-page":"66","article-title":"Analysis on the cause of death for children under 5 in hospitals from national death causes reporting system in 2010 in China","volume":"392","author":"Ye","year":"2012","journal-title":"Chin Women Child Health"},{"issue":"7","key":"10.1016\/j.vaccine.2019.01.009_b0085","first-page":"1442","article-title":"Analysis on the cause of death for children under 5 years in Shijingshan District, Bejing, China, 2003\u20132013","volume":"31","author":"Ren","year":"2016","journal-title":"Matern. Child Health Care China"},{"key":"10.1016\/j.vaccine.2019.01.009_b0090","doi-asserted-by":"crossref","unstructured":"Larson HJ, Smith DMD, Paterson P, et al. Measuring vaccine confidence: analysis of data obtained by a media surveillance system used to analyse public concerns about vaccines. https:\/\/doi.org\/10.1016\/s1473-3099(13)70108-7.","DOI":"10.1016\/S1473-3099(13)70108-7"},{"issue":"2","key":"10.1016\/j.vaccine.2019.01.009_b0095","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/ije\/dyv349","article-title":"Loss of confidence in vaccines following media reports of infant deaths after hepatitis B vaccination in China","volume":"45","author":"Yu","year":"2016","journal-title":"Int J Epidmiol"},{"key":"10.1016\/j.vaccine.2019.01.009_b0100","unstructured":"China Ministry of Health, Food and Drug Administration of China. Briefing media text Record progress of the investigation on the hepatitis B vaccine[EB\/OL]; 2014 [2014-1-3; cited 2016-7-1]. From <http:\/\/www.nhfpc.gov.cn\/xcs\/s3574\/201401\/e2fb92479a344d55a8bef1f96bf04166.shtml>."},{"issue":"2","key":"10.1016\/j.vaccine.2019.01.009_b0105","first-page":"147","article-title":"Investigation and Analysis of three cases of adverse events following immunization with Hepatitis B vaccine, reported by the media in Hunan, 2013","volume":"21","author":"Yan","year":"2015","journal-title":"Chin J Vacc Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2019.01.009_b0110","first-page":"97","article-title":"Analysis on surveillance data of adverse events following immunization in China, 2011","volume":"19","author":"Wu","year":"2013","journal-title":"Chin J Vacc Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2019.01.009_b0115","first-page":"1","article-title":"Analysis on surveillance data of adverse events following immunization in China, 2012","volume":"20","author":"Wu","year":"2014","journal-title":"Chin J Vacc Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2019.01.009_b0120","first-page":"121","article-title":"Evaluation of the adverse events following immunization information management system in China, 20 13","volume":"21","author":"Ye","year":"2015","journal-title":"Chin J Vacc Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2019.01.009_b0125","first-page":"125","article-title":"Analysis of surveillance for adverse events following immunization in China, 2014","volume":"22","author":"Ye","year":"2016","journal-title":"Chin J Vacc Immun"},{"issue":"5","key":"10.1016\/j.vaccine.2019.01.009_b0130","first-page":"481","article-title":"Surveillance of adverse events following immunization in China, 2015","volume":"23","author":"Ye","year":"2017","journal-title":"Chin J Vacc Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2019.01.009_b0135","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.vaccine.2015.11.018","article-title":"An approach to death as an adverse event following immunization","volume":"34","author":"Gold","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.01.009_b0140","doi-asserted-by":"crossref","first-page":"5771","DOI":"10.1016\/j.vaccine.2007.04.060","article-title":"Encephalitis, myelitis, and acute disseminated encephalomyelitis (ADEM): case definitions and guidelines for collection, analysis and presentation of immunization safety data","volume":"25","author":"Sejvar","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.01.009_b0145","doi-asserted-by":"crossref","first-page":"5793","DOI":"10.1016\/j.vaccine.2007.04.058","article-title":"Aseptic meningitis: case definition and guidelines for collection, analysis and presentation of immunization safety data","volume":"25","author":"Tapiainen","year":"2007","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2019.01.009_b0150","first-page":"704","article-title":"Report of a case with status thymicolymphaticus dies after vaccination and similar reports in China","volume":"32","author":"Zhang","year":"2011","journal-title":"J Capit Med Univ"},{"key":"10.1016\/j.vaccine.2019.01.009_b0155","series-title":"Causality assessment of an adverse event following immunization (AEFI): user manual for the revised WHO classification","author":"World Health Organization","year":"2018"},{"key":"10.1016\/j.vaccine.2019.01.009_b0160","doi-asserted-by":"crossref","first-page":"3288","DOI":"10.1016\/j.vaccine.2015.05.023","article-title":"Deaths following vaccination: what does the evidence show?","volume":"33","author":"Miller","year":"2015","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19300404?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19300404?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,8]],"date-time":"2019-10-08T18:04:33Z","timestamp":1570557873000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19300404"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":32,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S0264410X19300404"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.01.009","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Deaths reported to national surveillance for adverse events following immunization in China, 2010\u20132015","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.01.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}